Interstitial Cystitis: Clinical Trials

3 trials for Interstitial Cystitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Unknown 3
Phase 21Unknown 1

Follow Interstitial Cystitis: new trials by email Literature Review of Interstitial Cystitis trials Research Report on Interstitial Cystitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis
Interferon, Sodium Hyaluronate, Sodium Chloride Injection - Interstitial Cystitis
Phase 2 / Phase 3UnknownWest China Hospital1292023-10-152023-09-15
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
AQX-1125 100 mg, AQX-1125 200 mg, Placebo - Interstitial Cystitis, Bladder Pain Syndrome
Phase 3UnknownAquinox Pharmaceuticals (Canada) Inc.4332016-07-012018-03-15
Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms
Acupuncture - Interstitial Cystitis
Phase 3UnknownThe Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust602004-09-012005-06-24

Narrower conditions

Cystitis, Interstitial (3)  ·  Nocturia (1)  ·  Pelvic Pain (1)

Broader conditions

Cystitis (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Male Urogenital Diseases (3)  ·  Urinary Bladder Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Lower Urinary Tract Symptoms (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Urological Manifestations (1)

Interventions

4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol (1)  ·  Acupuncture Therapy (1)  ·  Hyaluronic Acid (1)  ·  Interferons (1)  ·  Sodium Chloride (1)

Sponsors

Aquinox Pharmaceuticals (Canada) Inc. (1)  ·  The Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust (1)  ·  West China Hospital (1)

Countries

United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Latvia (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Robert Moldwin, MD (1)  ·  Wei-min Li (1)

Results publications

PMID 38587846